Narges Bazgir | Medicine | Best Researcher Award

Published on by Global Academic Awards

Dr. Narges Bazgir | Medicine | Best Researcher Award

Post doc researcher at Shahid Beheshti university of Medical Sciences, Iran

Dr. Narges Bazgir, MD, MPH, HMBA, is a dedicated postdoctoral research fellow at the Hearing Disorder Research Center, Shahid Beheshti University of Medical Sciences 🎓🧠. With 40+ co-authored publications 📚, she blends clinical expertise with cutting-edge research in bioinformatics, AI, and neuroscience 🧬🤖. Skilled in advanced data analysis (SPSS, R, STATA), electrophysiology, and stem cell work 🧪, she excels in interdisciplinary collaboration and scientific innovation. A top-ranked medical graduate 🥇, she has received national recognition for her research in audiology and COVID-19. Passionate about solving healthcare challenges, Dr. Bazgir is a rising star in medical science 🌟.

Publication Profile📚

Google Scholar

Academic Background🎓

Dr. Narges Bazgir, MD, MPH, HMBA, is a highly accomplished medical researcher with a robust academic foundation. She earned her Doctor of Medicine (MD) from Shahid Beheshti University of Medical Sciences 🩺, followed by a Master of Public Health (MPH) with a focus on pandemic management strategies 🦠. Additionally, she completed a Health MBA at Tehran University of Medical Sciences 📊, enhancing her leadership in healthcare systems. Her exceptional academic achievements, including top national exam rankings 🏆, reflect her dedication and intellect. This diverse educational background empowers her to bridge clinical medicine with advanced research and innovation 🔬🌍.

Professional Experience💼

Dr. Narges Bazgir brings a dynamic blend of clinical and research expertise to the medical field. As a postdoctoral fellow at the Hearing Disorder Research Center 🧠, she leads and collaborates on innovative projects involving AI, bioinformatics, and electrophysiology 🧬⚡. She also serves as a clinical research fellow at Mofid Children’s Hospital 👶 and has contributed to multiple national cohorts and clinical trials. Alongside research, she has practiced medicine as an emergency physician and dialysis ward doctor 🏥. Her roles reflect a strong commitment to interdisciplinary teamwork, scientific advancement, and improving patient care through research and clinical service 🔬.

Awards and Honors🥇

Dr. Narges Bazgir has been widely recognized for her academic excellence and research achievements 🌟📚. She was selected as an Exceptional Talent for graduate admission at Shahid Beheshti University of Medical Sciences 🎓 and ranked in the top 0.05% out of over 600,000 applicants in Iran’s national medical entrance exam 🥇. She received the Ministry of Health’s grant as the youngest researcher for her AI-based study on cholesteatoma diagnosis 🤖🧠. Additionally, she earned recognition from the National Institute for Medical Research Development for her work on Long-COVID symptoms 🦠📈, reflecting her innovative and impactful contributions to medical science 🔬.

Research Focus🔬

Dr. Narges Bazgir’s research centers on the intersection of clinical medicine, neuroscience, and data-driven innovation 🧠📊. Her work spans hearing disorders, neurodegenerative diseases, immunological conditions, and infectious diseases like COVID-19 🦻🦠. She is highly skilled in systematic reviews, meta-analyses, and advanced bioinformatics, applying AI and machine learning to solve complex medical challenges 🤖🧬. Her projects include electrophysiological studies, stem cell research, and functional MRI analysis 🔬🧪. With over 40 publications, she integrates hands-on lab techniques with statistical modeling to produce impactful, translational research—aimed at enhancing diagnostics, treatment, and patient outcomes across disciplines 📈.

Publication Top Notes🌟

📄 Crimean-Congo hemorrhagic fever (CCHF) in Afghanistan: A retrospective single center study
🗓️ Year: 2021 | 🔁 Cited by: 28

📄 Assessment of prognostic biomarkers in sudden sensorineural hearing loss: a systematic review and meta-analysis
🗓️ Year: 2023 | 🔁 Cited by: 11

📄 COVID-19: National pandemic management strategies and their efficacies and impacts on secondary cases and prognosis: a systematic review
🗓️ Year: 2022 | 🔁 Cited by: 9

📄 A rare immunological disease, caspase 8 deficiency: case report and literature review
🗓️ Year: 2023 | 🔁 Cited by: 8

📄 Evaluation of the Association between Serum Levels of Vitamin D and Benign Paroxysmal Positional Vertigo (BPPV): A Case-Control Study
🗓️ Year: 2022 | 🔁 Cited by: 5

📄 Evaluation of the Relation between Tuning Fork Tests, Glue Ear Presence, and Conductive Hearing Loss in Patients with Otitis Media with Effusion
🗓️ Year: 2022 | 🔁 Cited by: 5

📄 Investigation of Clinical Manifestations and Laboratory Findings of COVID-19 During National Peaks of Alpha, Beta, Delta, and Omicron in the Pediatric Emergency Department
🗓️ Year: 2023 | 🔁 Cited by: 4

📄 Two Unrelated Iranian Patients with Adenosine Deaminase 2 Deficiency: A Case Report and Review of Treatment
🗓️ Year: 2024 | 🔁 Cited by: 2

📄 Manifestations of Mucormycosis and Its Complications in COVID-19 Patients: A Case Series Study
🗓️ Year: 2024 | 🔁 Cited by: 1

📄 Bell’s palsy and sudden sensorineural hearing loss simultaneously post COVID-19: A case report and review
🗓️ Year: 2024 | 🔁 Cited by: 1

📄 Efficacy Comparison Between Interscalene Block with and Without Superficial Cervical Plexus Block for Anesthesia in Clavicle Surgery
🗓️ Year: 2024 | 🔁 Cited by: 1

Conclusion

Dr. Narges Bazgir stands out as an exceptional candidate for the Best Researcher Award, with a rare combination of clinical expertise, scientific innovation, and interdisciplinary excellence. With over 40 publications spanning systematic reviews, rare diseases, and COVID-19 epidemiology, she has demonstrated impressive productivity and impact. Her dual mastery of laboratory techniques and advanced data analytics—including AI, bioinformatics, and fMRI—highlights her technical versatility. Holding an MD, MPH, and HMBA, and having received multiple national honors, she exemplifies leadership and innovation in translational research. Her collaborative spirit, early career achievements, and visionary contributions make her a truly outstanding nominee. 🌟🔬📚

 

 

Oswaldo Aguilar | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Oswaldo Aguilar | Medicine and Dentistry | Best Researcher Award

Dr Oswaldo Aguilar, Universidad del Valle, Colombia

Dr. Oswaldo Aguilar 🩺❤️ is a cardiologist and echocardiography specialist at Hospital Universitario del Valle, Colombia. He also serves as a lecturer at Universidad del Valle and Universidad Libre. Dr. Aguilar holds a medical degree from Universidad Rafael Núñez and specialized in Internal Medicine and Clinical Cardiology. A prolific author, he has contributed to key medical textbooks and journals 📚. He is a member of the American College of Physicians, the Sociedad Colombiana de Cardiología, and ESC. Passionate about cardiovascular imaging and heart failure research, Dr. Aguilar actively shapes future medical professionals through teaching and mentorship. 🎓💉

Publication Profile

Scopus

Clinical Expertise and Teaching

Dr. Oswaldo Aguilar is a dedicated cardiologist and medical educator 🩺❤️. Since January 2024, he has worked at Hospital Universitario del Valle in advanced cardiac imaging. He also teaches postgraduate internal medicine and cardiology at Universidad del Valle and Universidad Libre, Cali 👨‍🏫. Dr. Aguilar has been a cardiologist at Colsanitas S.A. since 2022. Previously, he completed a cardiology fellowship at Universidad de Antioquia and practiced internal medicine at Hospital Universitario del Valle and Fundación Valle de Lili 🏥. His experience spans urgent care, hospital wards, and intensive care, showcasing his commitment to patient care and medical training.

Complementaria

Dr. Oswaldo Aguilar is a dedicated cardiologist with advanced training in cardiovascular imaging and clinical care ❤️‍🩹. He completed an ultrasound program for major syndromes at Universidad Cardenal Herrera (2019-2020) and holds diplomas in cardiovascular medicine 🫀 and clinical research 📊. His expertise spans heart failure management, anticoagulation, and pulmonary hypertension. He has extensive hands-on training, including a 2024 rotation in advanced cardiac imaging at Hospital Clínico San Carlos, Madrid 🏥. Certified in ACLS and trauma care, Dr. Aguilar is a Fellow in Training with the ACC (2020-2023) and proficient in POCUS imaging techniques 📈.

Recognition and Affiliations

Dr. Oswaldo Aguilar is a distinguished cardiologist with memberships in prestigious organizations, including the American College of Physicians 🩺, Sociedad Colombiana de Cardiología ❤️, and the European Society of Cardiology (ESC) 🌍. His affiliations reflect his dedication to advancing cardiovascular medicine and active participation in global cardiology networks. Dr. Aguilar’s involvement in these esteemed societies highlights his commitment to staying at the forefront of medical research and innovation, fostering collaboration with experts worldwide. Through these connections, he continually enhances his expertise, contributing to improved patient care and shaping the future of cardiology.

Research Focus

Dr. Oswaldo Aguilar’s research focuses on cardiovascular health 🫀, particularly in echocardiographic findings, aortic stenosis, heart failure, and coronary artery disease. His studies analyze systemic lupus erythematosus patients, mortality predictors, and atrial fibrillation treatments. Dr. Aguilar’s work spans retrospective cohort studies and practical reviews, emphasizing real-world applications in cardiology clinics and emergency rooms 🏥. His publications address critical issues like prosthetic valve thrombosis, aiming to improve patient outcomes through advanced diagnostic and therapeutic strategies. Dr. Aguilar’s contributions reflect a dedication to enhancing cardiovascular care and advancing knowledge in cardiology 📚❤️.

Publication Top Notes

Echocardiographic findings in patients with systemic lupus erythematosus: Retrospective analysis in a tertiary referral centre | Hallazgos ecocardiográficos en pacientes con lupus eritematoso sistémico: análisis retrospectivo en un centro de referencia terciaria

Low-Flow, Low-Gradient Severe Aortic Stenosis in patients with preserved or reduced ejection fraction: a systematic literature review.

Application of eligibility criteria from DAPA-HF, EMPEROR-Reduced, and PARADIGM-HF trials to a population with heart failure with reduced ejection fraction at a specialized cardiology Clinic in Medellin, Colombia: A retrospective cohort study

Atrial fibrillation treatment in the emergency room: a practical narrative review | Tratamiento de la fibrilación auricular en el servicio de urgencias: una revisión práctica de la literatura

Predictors of mortality in patients with coronary artery disease and involvement of the left main artery | Factores predictores de mortalidad en pacientes con enfermedad coronaria y compromiso del tronco principal izquierdo

Prosthetic valve thrombosis and thrombolytic therapy in the modern era: a case report | Trombosis valvular y terapia trombolítica en la era moderna: reporte de un caso

 

Min-ran Li | Medicine and Dentistry | Women Researcher Award

Published on by Global Academic Awards

Ms. Min-ran Li | Medicine and Dentistry | Women Researcher Award

Ms. Min-ran Li, The First Affiliated Hospital of Jinan University, China

Dr. Minran Li is the Chief Physician at the Division of Infectious Disease at The First Affiliated Hospital of Jinan University. He earned his M.D. in Internal Medicine from Peking University and has extensive expertise in infectious diseases, particularly nonalcoholic steatohepatitis (NASH) and chronic hepatitis B. His research focuses on discovering noninvasive biomarkers and the molecular mechanisms behind liver diseases. Dr. Li has published numerous articles and has been recognized as a Guangdong High-Level Personnel of Young Talents. 🏥📚

Publication Profile

Scopus

 

Education

Ms. Li holds an M.D. in Internal Medicine (Infectious Disease) from Beijing Peking University, a Master’s in Internal Medicine from Hebei Medical University, and a Bachelor’s in Clinical Medicine. This strong educational foundation has empowered her expertise in infectious diseases, particularly liver-related conditions like NASH (nonalcoholic steatohepatitis) and CHB (chronic hepatitis B).

Work Experience

Currently serving as Chief Physician in the Division of Infectious Diseases at the First Affiliated Hospital of Jinan University, Ms. Li has progressively taken on roles of increasing responsibility, including as Associate Chief Physician at The Fifth Hospital of Shijiazhuang. Her work centers on managing liver diseases and exploring innovative biomarkers.

Research Interests

Her research focuses on discovering noninvasive biomarkers for pathological features of NASH in combination with CHB. Her findings on the role of HIGD1A and fibrosis development in liver disease have been pivotal in identifying therapeutic targets, advancing the understanding of liver disease progression.

Awards and Recognitions

Her dedication has been recognized with honors such as the Guangdong High-Level Personnel of Young Talents Program and the Yangcheng Good Doctor Award, underscoring her excellence in medical research and practice.

Conclusion

Ms. Min-ran Li’s strong academic background, leadership in liver disease research, and national and international recognition make her a strong candidate for the Research for Women Researcher Award.

 

Publication Top Notes

  • Pan, Y. et al. (2024). Overexpression of LAG-3: a potential indicator of low immune function in tuberculosis. Frontiers in Cellular and Infection Microbiology, 14, 1410015. 🦠 (0 citations)
  • Li, M.-R. et al. (2024). The function role of HIGD1A in nonalcoholic steatohepatitis from chronic hepatitis B. Scandinavian Journal of Gastroenterology, 59(4), 445–455. 🥗 (0 citations)
  • Li, J.-Z. et al. (2023). Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis. Molecules, 28(23), 7936. 🌿 (0 citations)
  • Li, M.-R. et al. (2023). Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population. Obesity Facts, 16(5), 427–434. 🍔 (1 citation)
  • Pan, Y. et al. (2023). Immune checkpoint inhibitors in cancer patients with COVID-19. Open Life Sciences, 18(1), 20220641. 💉 (1 citation)
  • Li, J.-Z. et al. (2022). Characteristics and treatment strategies for hepatocellular carcinoma caused by nonalcoholic fatty liver disease. Zhonghua gan zang bing za zhi, 30(12), 1392–1396. 🏥 (0 citations)
  • Yang, L. et al. (2022). Progress in research of lipogenesis inhibitors for treatment of nonalcoholic fatty liver disease. World Chinese Journal of Digestology, 30(16), 735–742. 🧬 (1 citation)
  • Li, J.-Z. et al. (2021). The identify role and molecular mechanism of the MALAT1/hsa-mir-20b-5p/TXNIP axis in liver inflammation caused by CHB in patients with chronic HBV infection complicated with NAFLD. Virus Research, 298, 198405. 🔬 (20 citations)
  • Zheng, X.-L. et al. (2021). Effect of optimizing oxygen therapy on multiple organ function and prognosis of patients with COVID-19. Chinese Journal of Pathophysiology, 37(5), 909–914. 🫁 (0 citations)
  • Li, M.-R. et al. (2020). Clinical features of hepatitis B patients at immune-tolerance phase with basal core promoter and/or precore mutations. Journal of Viral Hepatitis, 27(10), 1044–1051. 🦠 (4 citations)